Back to All

Diaceutics CEO, Peter Keeling named in The Business & Finance CEO 100 Index 2022

6 April, 2022

Featured

Diaceutics CEO, Peter Keeling has been named in The Business & Finance CEO 100 Index 2022, which recognises the top 100 Chief Executive Officers working across some of the most innovative companies in Ireland and the UK.

Business & Finance magazine recognised Peter as a thought leader in Personalized Medicine commercialisation, who has driven Diaceutics to become a leader in innovative solutions that enable pharma to leverage diagnostic testing globally. Under his leadership, Diaceutics has grown significantly since its inception in 2005 and now works with 39 of the top pharma companies in the world. 

Click here to read more: Business & Finance CEO 100 Index 2022 — Part 2 - Business & Finance | Business & Finance (businessandfinance.com)

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane
London
EC4V 5EQ.

Tel: +44 (0)20 3405 0205 or [email protected]


 
Caroline Forde
Robyn Fisher
 
Kieran Breheny